Edges in Network
Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
Node | CYP2A13 |
Upstream (Parents) |
---|
(<<) MLXIPL → CYP2A13 |
(<<) CYP2A7 → CYP2A13 |
(<<) SULT1E1 → CYP2A13 |
(<<) RAB17 → CYP2A13 |
(<<) DAK → CYP2A13 |
(<<) ACBD4 → CYP2A13 |
Downstream (Children) |
---|
CYP2A13 → KIF26B (>>) |
CYP2A13 → MTRF1L (>>) |
CYP2A13 → LUZP4 (>>) |
CYP2A13 → CCNK (>>) |
CYP2A13 → CCL1 (>>) |
CYP2A13 → ODF1 (>>) |